首页> 外国专利> HUMAN MELANOMA CELLULAR LINE mel Kor USED IN PREPARING ANTITUMOR VACCINE

HUMAN MELANOMA CELLULAR LINE mel Kor USED IN PREPARING ANTITUMOR VACCINE

机译:人黑素细胞系mel Kor用于制备抗痘疫苗

摘要

FIELD: biotechnology, oncology.;SUBSTANCE: invention relates to a novel prepared human melanoma cellular line mel Kor that possesses stable cultural and morphological indices and stored in the Specialized collection of cellular cultures of Cytology institute at number PKKK (P) 687D. The cellular line is characterized by expression of melanoma (differentiating) markers - CD-63, HMB-45, HMW, MelanA and Tyrozinaza and cancer-testicular marker MAGE-3 also and absence of histo-compatibility antigens of the first and the second class. The cellular line can be used for creature of antitumor (all-cell, genetic engineering) vaccines used in treatment of melanoma and other malignant neoplasms. Using the invention provides preparing the novel effective antitumor vaccine and can be used in medicine for vaccine therapy of malignant neoplasms.;EFFECT: valuable medicinal properties of cellular line.;1 tbl, 2 ex
机译:发明领域本发明涉及具有稳定的培养和形态学指标并且以PKKK(P)687D号保存在细胞学研究所细胞培养的专门收藏中的新制备的人黑素瘤细胞系mel Kor。该细胞系的特征是黑色素瘤(分化)标记物-CD-63,HMB-45,HMW,MelanA和Tyrozinaza的表达以及癌-睾丸标记物MAGE-3的表达,并且不存在第一类和第二类组织相容性抗原。细胞系可用于治疗黑色素瘤和其他恶性肿瘤的抗肿瘤疫苗(全细胞,基因工程)。使用本发明提供了制备新型有效的抗肿瘤疫苗,并可用于恶性肿瘤的疫苗治疗的药物。效果:细胞系的有价值的药物特性。1 tbl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号